Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia

被引：8

作者：

Milojkovic, D

Short, K

Salisbury, JR

Creamer, D

du Vivier, AWP

Mufti, GJ

机构：

[1] Kings Coll Hosp London, Dept Haematol Med, GKT Sch Med, London SE5 9RS, England

[2] Kings Coll Hosp London, Dept Dermatol, London, England

[3] GKT Sch Med, Dept Histopathol, London, England

来源：

LEUKEMIA | 2003年 / 17卷 / 07期

关键词：

D O I：

10.1038/sj.leu.2402991

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1414 / 1416

页数：3

共 8 条

[1] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[2] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[3] Cerebral oedema as a possible complication of treatment with imatinib [J].

Ebnöether, M ;

Stentoft, J ;

Ford, J ;

Buhl, L ;

Gratwohl, A .

LANCET, 2002, 359 (9319) :1751-1752

[4] Particle-mediated gene transfer of PDGF isoforms promotes wound repair [J].

Eming, SA ;

Whitsitt, JS ;

He, L ;

Krieg, T ;

Morgan, JR ;

Davidson, JM .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (03) :297-302

[5] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].

Kantarjian, H ;

Sawyers, C ;

Hochhaus, A ;

Guilhot, F ;

Schiffer, C ;

Gambacorti-Passerini, C ;

Niederwieser, D ;

Resta, D ;

Capdeville, R ;

Zoellner, U ;

Talpaz, M ;

Druker, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652

[6]

Larson RA, 2002, BLOOD, V100, p4A

[7]

Pietras K, 2001, CANCER RES, V61, P2929

[8] Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study [J].

Sawyers, CL ;

Hochhaus, A ;

Feldman, E ;

Goldman, JM ;

Miller, CB ;

Ottmann, OG ;

Schiffer, CA ;

Talpaz, M ;

Guilhot, F ;

Deininger, MWN ;

Fischer, T ;

O'Brien, SG ;

Stone, RM ;

Gambacorti-Passerini, CB ;

Russell, NH ;

Reiffers, JJ ;

Shea, TC ;

Chapuis, B ;

Coutre, S ;

Tura, S ;

Morra, E ;

Larson, RA ;

Saven, A ;

Peschel, C ;

Gratwohl, A ;

Mandelli, F ;

Ben-Am, M ;

Gathmann, I ;

Capdeville, R ;

Paquette, RL ;

Druker, BJ .

BLOOD, 2002, 99 (10) :3530-3539

← 1 →